New challenges for lung transplantation in the era of COVID-19

Abstract

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in late 2019 and has caused immense numbers of hospitalizations and deaths worldwide. There have now been more than 190 million diagnosed cases and more than 4 million deaths, according to the Johns Hopkins coronavirus center. 1 Organ transplantation,

Hospitalized patients with irreversible lung injury from COVID-19 have higher morbidity but similar 1-year survival after lung transplant compared to hospitalized patients transplanted for restrictive lung disease

“…Patients with irreversible lung injury due to COVID-19 depend on LT for survival; however, their LT candidacy is often challenged by critical illness, malnutrition, and extrathoracic complications. 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15…”